Vertebral fractures are the most prevalent osteoporotic fractures worldwide and are particularly prevalent in postmenopausal women. The last major population-based study assessing the prevalence of vertebral fractures in the United States was the Study of Osteoporotic Fractures (1999). Since then, studies have been limited by sample size and population generalizability.
Patients and Methods:
The PearlDiver M165 database was used to obtain a randomized sample of 500,000 women over age 55. Women with a diagnosed vertebral fracture were identified via International Classification of Diseases codes and compared with those without by multivariate analysis of potential risk factors: age, geographic region, insurance, diabetes, substance use, osteoporosis history, premature menopause, body mass index (BMI), and hormone replacement therapy (HRT) (estrogen alone versus combination therapy). Dual-x-ray absorptiometry scan utilization was also analyzed.
Results:
15,328 of 500,000 women were newly diagnosed with vertebral fracture. Predictors of fracture included older age (age 75+ odds ratios [OR]: 3.92), geographic region, insurance (Medicaid OR: 1.26, Medicare OR: 1.06 versus commercial), diabetes (Type 1 OR: 1.12, Type 2 OR: 1.10), substance use (tobacco OR: 1.52, alcohol OR: 1.60, opioid OR: 1.94), osteoporosis (with fracture history OR: 3.92, without OR: 2.91), and decreased BMI (BMI < 18.5 OR: 1.31, with increasing BMI incrementally protective). Combination HRT did not significantly alter odds of vertebral fracture compared with estrogen alone.
Conclusions:
This study provides an updated and nationally representative estimation of vertebral fracture prevalence among postmenopausal women in the United States (3.07% diagnosed, extrapolated to approximately 9.3% prevalence) and highlights risk factors associated with fracture, with the goal of improving screening and management in postmenopausal women.
BallaneG, CauleyJA, LuckeyMM, et al.Worldwide prevalence and incidence of osteoporotic vertebral fractures. Osteoporos Int, 2017; 28(5):1531–1542; doi: 10.1007/s00198-017-3909-3
2.
VokesTJ, GillenDL, PhamAT, et al.Risk factors for prevalent vertebral fractures in black and white female densitometry patients. J Clin Densitom, 2007; 10(1):1–9; doi: 10.1016/j.jocd.2006.11.002
3.
AlexandruD, SoW. Evaluation and management of vertebral compression fractures. Perm J, 2012; 16(4):46–51.
4.
MeltonLJ, KanSH, FryeMA, et al.Epidemiology of vertebral fractures in women. Am J Epidemiol, 1989; 129(5):1000–1011; doi: 10.1093/oxfordjournals.aje.a115204
5.
RostomS, AllaliF, BennaniL, et al.The prevalence of vertebral fractures and health-related quality of life in postmenopausal women. Rheumatol Int, 2012; 32(4):971–980; doi: 10.1007/s00296-010-1734-5
6.
KadoDM, BrownerWS, PalermoL, et al.Vertebral fractures and mortality in older women: A prospective study. Arch Intern Med, 1999; 159(11):1215–1220; doi: 10.1001/archinte.159.11.1215
7.
O’NeillTW, FelsenbergD, VarlowJ, et al.The prevalence of vertebral deformity in European men and women: The European vertebral osteoporosis study. J Bone Miner Res, 1996; 11(7):1010–1018; doi: 10.1002/jbmr.5650110719
8.
FelsenbergD, SilmanAJ, LuntM, et al.; European Prospective Osteoporosis Study (EPOS) Group. Incidence of vertebral fracture in Europe: Results from the European prospective osteoporosis study (EPOS)*. J Bone Miner Res, 2002; 17(4):716–724; doi: 10.1359/jbmr.2002.17.4.716
9.
HernlundE, SvedbomA, IvergårdM, et al.Osteoporosis in the European union: Medical management, epidemiology and economic burden. Arch Osteoporos, 2013; 8(1):136; doi: 10.1007/s11657-013-0136-1
10.
WaterlooS, AhmedLA, CenterJR, et al.Prevalence of vertebral fractures in women and men in the population-based Tromsø study. BMC Musculoskelet Disord, 2012; 13(1):3; doi: 10.1186/1471-2474-13-3
11.
LingX, CummingsSR, MingweiQ, et al.Vertebral fractures in Beijing, China: The Beijing osteoporosis project. J Bone Miner Res, 2000; 15(10):2019–2025; doi: 10.1359/jbmr.2000.15.10.2019
12.
ClarkP, Cons-MolinaF, DelezeM, et al.The prevalence of radiographic vertebral fractures in Latin American countries: The Latin American Vertebral Osteoporosis Study (LAVOS). Osteoporos Int, 2009; 20(2):275–282; doi: 10.1007/s00198-008-0657-4
13.
JacksonSA, TenenhouseA, RobertsonL. Vertebral fracture definition from population-based data: Preliminary results from the Canadian Multicenter Osteoporosis Study (CaMos). Osteoporos Int, 2000; 11(8):680–687; doi: 10.1007/s001980070066
14.
PirroM, FabbricianiG, LeliC, et al.High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women. J Bone Miner Metab, 2010; 28(1):88–93; doi: 10.1007/s00774-009-0108-0
15.
TanakaS, KurodaT, SaitoM, et al.Overweight/obesity and underweight are both risk factors for osteoporotic fractures at different sites in Japanese postmenopausal women. Osteoporos Int, 2013; 24(1):69–76; doi: 10.1007/s00198-012-2209-1
16.
CompstonJE, FlahiveJ, HosmerDW, et al.; GLOW Investigators. Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: The Global Longitudinal study of Osteoporosis in Women (GLOW). J Bone Miner Res, 2014; 29(2):487–493; doi: 10.1002/jbmr.2051
17.
KomulainenMH, KrogerH, TuppurainenMT, et al.HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas, 2008; 61(1–2):85–94; doi: 10.1016/j.maturitas.2008.09.012
18.
NaessénT, PerssonI, AdamiH-O, et al.Hormone replacement therapy and the risk for first hip fracture. Ann Intern Med, 1990; 113(2):95–103; doi: 10.7326/0003-4819-113-2-95
19.
StepanJJ, HruskovaH, KverkaM. Update on menopausal hormone therapy for fracture prevention. Curr Osteoporos Rep, 2019; 17(6):465–473; doi: 10.1007/s11914-019-00549-3
20.
BanksE, BeralV, ReevesG, et al.; Million Women Study Collaborators. Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women. JAMA, 2004; 291(18):2212–2220; doi: 10.1001/jama.291.18.2212
21.
Sanfélix-GimenoG, Sanfelix-GenovésJ, HurtadoI, et al.Vertebral fracture risk factors in postmenopausal women over 50 in Valencia, Spain. A population-based cross-sectional study. Bone, 2013; 52(1):393–399; doi: 10.1016/j.bone.2012.10.022
22.
CuiL, ChenL, XiaW, et al.Vertebral fracture in postmenopausal Chinese women: A population-based study. Osteoporos Int, 2017; 28(9):2583–2590; doi: 10.1007/s00198-017-4085-1
23.
TobiasJH, HutchinsonAP, HuntLP, et al.Use of clinical risk factors to identify postmenopausal women with vertebral fractures. Osteoporos Int, 2007; 18(1):35–43; doi: 10.1007/s00198-006-0209-8
24.
KilincerC, Demirbag KabayelD, CagliB, et al.Frequency, distribution and severity of prevalent osteoporotic vertebral fractures in postmenopausal women. Turk Neurosurg, 2013; 23(4):476–483; doi: 10.5137/1019-5149.JTN.7442-12.0
25.
KammienAJ, GalivancheAR, JooPY, et al.Comparison of postoperative outcomes in patients with and without osteoporosis undergoing single-level anterior cervical discectomy and fusion. N Am Spine Soc J, 2022; 12:100174; doi: 10.1016/j.xnsj.2022.100174
26.
KatsnelsonBM, RancuAL, WinterAD, et al.Preoperative anxiety: An important risk factor of postoperative adverse events and increased reoperation rates in patients undergoing single-level anterior cervical Diskectomy and fusion. JAAOS Glob Res Rev, 2024; 8(10):e24; doi: 10.5435/JAAOSGlobal-D-24-00204
27.
HalperinSJ, DhodapkarMM, GouzoulisM, et al.Lumbar laminotomy: Variables affecting 90-day overall reimbursement. J Am Acad Orthop Surg, 2024; 32(6):265–270; doi: 10.5435/JAAOS-D-23-00365
28.
KimLY, HalperinSJ, GrauerJN. Surgical site infection following isolated lumbar discectomy increases odds of revision lumbar surgery within first 6 months, but not beyond. Spine J, 2024; 24(8):1459–1466; doi: 10.1016/j.spinee.2024.03.017
29.
SeddioAE, KatsnelsonBM, Smith-VoudourisJ, et al.Inflammatory bowel disease is associated with greater odds of complications following posterior lumbar fusion and further amplified for patients exposed to biologics. N Am Spine Soc J, 2024; 20(0):100574; doi: 10.1016/j.xnsj.2024.100574
30.
SingerA, ExuzidesA, SpanglerL, et al.Burden of illness for osteoporotic fractures compared with other serious diseases among postmenopausal women in the United States. Mayo Clin Proc, 2015; 90(1):53–62; doi: 10.1016/j.mayocp.2014.09.011
31.
OhtoriS, InoueG, OritaS, et al.Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976), 2013; 38(8):E487–E492; doi: 10.1097/BRS.0b013e31828826dd
32.
BrechGC, PlaplerPG, de Souza MeirellesE, et al.Evaluation of the association between osteoporosis and postural balance in postmenopausal women. Gait Posture, 2013; 38(2):321–325; doi: 10.1016/j.gaitpost.2012.12.012
33.
CooperC, AtkinsonEJ, O’FallonWM, et al.Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res, 1992; 7(2):221–227; doi: 10.1002/jbmr.5650070214
34.
FinkHA, MilavetzDL, PalermoL, et al.; Fracture Intervention Trial Research Group. What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa? J Bone Miner Res, 2005; 20(7):1216–1222; doi: 10.1359/JBMR.050314
35.
KuoD-P, ChiuY-W, ChenP-T, et al.Associations between body composition and vertebral fracture risk in postmenopausal women. Osteoporos Int, 2022; 33(3):589–598; doi: 10.1007/s00198-021-06178-w
36.
SoneT, TomomitsuT, MiyakeM, et al.Age-related changes in vertebral height ratios and vertebral fracture. Osteoporos Int, 1997; 7(2):113–118; doi: 10.1007/BF01623685
37.
GotliebEG, RhodesKV, CandonMK. Disparities in primary care wait times in Medicaid versus commercial insurance. J Am Board Fam Med, 2021; 34(3):571–578; doi: 10.3122/jabfm.2021.03.200496
38.
McCARTHYJ, DavisA. Diagnosis and management of vertebral compression fractures. AFP, 2016; 94(1):44–50.
39.
CharipovaK, KayeAD, GressK. Vertebral compression fractures. In: Cambridge Handbook of Pain Medicine. (UritsI, ViswanathO. eds.) Cambridge University Press: Cambridge; 2023; pp. 107–118; doi: 10.1017/9781108979849.017
40.
KoromaniF, GhatanS, van HoekM, et al.Type 2 diabetes mellitus and vertebral fracture risk. Curr Osteoporos Rep, 2021; 19(1):50–57; doi: 10.1007/s11914-020-00646-8
41.
BaiJ, GaoQ, WangC, et al.Diabetes mellitus and risk of low-energy fracture: A meta-analysis. Aging Clin Exp Res, 2020; 32(11):2173–2186; doi: 10.1007/s40520-019-01417-x
42.
PoianaC, CapatinaC. Fracture risk assessment in patients with diabetes mellitus. J Clin Densitom, 2017; 20(3):432–443; doi: 10.1016/j.jocd.2017.06.011
43.
DedeAD, TournisS, DontasI, et al.Type 2 diabetes mellitus and fracture risk. Metabolism, 2014; 63(12):1480–1490; doi: 10.1016/j.metabol.2014.09.002
44.
KhiyaliZ, RashediV, TavacolZ, et al.Smoking, alcohol consumption, drug abuse, and osteoporosis among older adults: A cross-sectional study on PERSIAN cohort study in Fasa. BMC Geriatr, 2024; 24(1):80; doi: 10.1186/s12877-024-04678-y
45.
TeleraS, RausL, PipolaV, et al.Osteoporotic vertebral fractures. In: Vertebral Body Augmentation, Vertebroplasty and Kyphoplasty in Spine Surgery. (TeleraS, RausL, PipolaV eds.) Springer International Publishing: Cham; 2021; pp. 133–148; doi: 10.1007/978-3-030-76555-2_9
46.
TosiLL, GliklichR, KannanK, et al.The American orthopaedic association’s “own the bone” initiative to prevent secondary fractures. JBJS, 2008; 90(1):163–173; doi: 10.2106/JBJS.G.00682
47.
AnagnostisP, SiolosP, GkekasNK, et al.Association between age at menopause and fracture risk: A systematic review and meta-analysis. Endocrine, 2019; 63(2):213–224; doi: 10.1007/s12020-018-1746-6
48.
FaubionSS, KuhleCL, ShusterLT, et al.Long-term health consequences of premature or early menopause and considerations for management. Climacteric, 2015; 18(4):483–491; doi: 10.3109/13697137.2015.1020484
49.
KazeAD, RosenHN, PaikJM. A meta-analysis of the association between body mass index and risk of vertebral fracture. Osteoporos Int, 2018; 29(1):31–39; doi: 10.1007/s00198-017-4294-7
50.
EngelP, FabreA, FournierA, et al.Risk of osteoporotic fractures after discontinuation of menopausal hormone therapy: Results from the E3N cohort. Am J Epidemiol, 2011; 174(1):12–21; doi: 10.1093/aje/kwr044
51.
MichaëlssonK, BaronJA, JohnellO, et al.Variation in the efficacy of hormone replacement therapy in the prevention of hip fracture. Osteoporos Int, 1998; 8(6):540–546; doi: 10.1007/s001980050096
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
